Price $248.14 |
Market Cap
34.88B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
33.1
|
P/B
6.33
|
P/S
2.45
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
23.5
|
Op. Cash Flow
2.24M
|
FCF
8.3
|
|
Op. Margin
12.40%
|
Net Margin
7.40%
|
ROE
19.20%
|
ROI
8.20%
|
|
ROA
4.30%
|
EPS Growth
-3.10%
|
Current Ratio
0.9
|
Debt/Equity
222.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.03 | - | - | 6.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
